SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

Developing Novel Mechanism of Action Antivirals for Bunyavirus Therapeutics
Award last edited on: 8/21/2024

Sponsored Program
SBIR
Awarding Agency
DOD : CBD
Total Award Amount
$548,494
Award Phase
2
Solicitation Topic Code
CBD212-006
Principal Investigator
Anuj Singhal

Company Information

CFD Research Corporation (AKA: Computational Fluid Dynamics Research~E Combustors~CFDRC)

6820 Moquin Drive NW
Huntsville, AL 35806
   (256) 361-0811
   info@cfdrc.com
   www.cfdrc.com
Location: Single
Congr. District: 05
County: Madison

Phase I

Contract Number: N/A
Start Date: 5/15/2023    Completed: 5/18/2025
Phase I year
2023
Phase I Amount
$1
Direct to Phase II

Phase II

Contract Number: W911SR-23-C-0014
Start Date: 5/15/2023    Completed: 5/18/2025
Phase II year
2023
Phase II Amount
$548,493
This project seeks to develop a new broad-spectrum antiviral drug against viruses from the Bunyavirales family. These viruses have been designated as being among the highest potential to cause the next pandemic. CFD Research is advancing a natural product-derived antiviral chemistry that has demonstrated strong in vitro potency against Bunyaviruses with low cytotoxicity. We seek to produce an optimized lead candidate from this project.